Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

被引:253
|
作者
McMullen, Julie R. [1 ]
Amirahmadi, Fatemeh
Woodcock, Elizabeth A.
Schinke-Braun, Martina
Bouwman, Russell D.
Hewitt, Kimberly A.
Mollica, Janelle P.
Zhang, Li
Zhang, Yunyu
Shioi, Tetsuo
Buerger, Antje
Izumo, Seigo
Jay, Patrick Y.
Jennings, Garry L.
机构
[1] Baker Heart Res Inst, Expt Cardiol & Heart Failure Div, Melbourne, Vic 8008, Australia
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA
[3] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[4] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
关键词
heart failure; signal transduction; heart growth; athlete's heart;
D O I
10.1073/pnas.0606663104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Physical activity protects against cardiovascular disease, and physiological cardiac hypertrophy associated with regular exercise is usually beneficial, in marked contrast to pathological hypertrophy associated with disease. The p110 alpha isoform of phosphoinositide 3-kinase (PI3K) plays a critical role in the induction of exercise-induced hypertrophy. Whether it or other genes activated in the athlete's heart might have an impact on cardiac function and survival in a setting of heart failure is unknown. To examine whether progressive exercise training and PI3K(p110 alpha) activity affect survival and/or cardiac function in two models of heart disease, we subjected a transgenic mouse model of dilated cardiomyopathy (DCM) to swim training, genetically crossed cardiac-specific transgenic mice with increased or decreased PI3K(p110 alpha) activity to the DCM model, and subjected PI3K(p110 alpha) transgenics to acute pressure overload (ascending aortic constriction). Life span, cardiac function, and molecular markers of pathological hypertrophy were examined. Exercise training and increased cardiac PI3K(p110 alpha) activity prolonged survival in the DCM model by 15-20%. In contrast, reduced PI3K(p110 alpha) activity drastically shortened lifespan by approximate to 50%. Increased PI3K(p110 alpha) activity had a favorable effect on cardiac function and fibrosis in the pressure-overload model and attenuated pathological growth. PI3K(p110 alpha) signaling negatively regulated G protein-coupled receptor stimulated extracellular responsive kinase and Akt (via PI3K, p110 gamma) activation in isolated cardiomyocytes. These findings suggest that exercise and enhanced PI3K(p110 alpha) activity delay or prevent progression of heart disease, and that supraphysiologic activity can be beneficial. Identification of genes important for hypertrophy in the athlete's heart could offer new strategies for treating heart failure.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 50 条
  • [31] The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ
    Guillermet-Guibert, Julie
    Bjorklof, Katja
    Salpekar, Ashreena
    Gonella, Cristiano
    Ramadani, Faruk
    Bilancio, Antonio
    Meek, Stephen
    Smith, Andrew J. H.
    Okkenhaug, Klaus
    Vanhaesebroeck, Bart
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (24) : 8292 - 8297
  • [32] Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
    Burke, John E.
    Vadas, Oscar
    Berndt, Alex
    Finegan, Tara
    Perisic, Olga
    Williams, Roger L.
    STRUCTURE, 2011, 19 (08) : 1127 - 1137
  • [33] Requirement for phosphoinositide 3-kinase p110δ signaling in B cell antigen receptor-mediated antigen presentation
    Al-Alwan, Monther M.
    Okkenhaug, Klaus
    Vanhaesebroeck, Bart
    Hayflick, Joel S.
    Marshall, Aaron J.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (04): : 2328 - 2335
  • [34] Gαq binds to p110α/p85α phosphoinositide 3-kinase and displaces Ras
    Ballou, LM
    Chattopadhyay, M
    Li, Y
    Scarlata, S
    Lin, RZ
    BIOCHEMICAL JOURNAL, 2006, 394 : 557 - 562
  • [35] Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110γ
    Kurig, Barbara
    Shymanets, Aliaksei
    Bohnacker, Thomas
    Prajwal
    Brock, Carsten
    Ahmadian, Mohammad Reza
    Schaefer, Michael
    Gohla, Antje
    Harteneck, Christian
    Wymann, Matthias P.
    Jeanclos, Elisabeth
    Nuernberg, Bernd
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) : 20312 - 20317
  • [36] Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ
    Brock, C
    Schaefer, M
    Reusch, HP
    Czupalla, C
    Michalke, M
    Spicher, K
    Schultz, G
    Nürnberg, B
    JOURNAL OF CELL BIOLOGY, 2003, 160 (01): : 89 - 99
  • [37] PHOSPHOINOSITIDE 3-KINASE P110{GAMMA} IS REQUIRED FOR BACTERIAL CLEARANCE AND THE RESOLUTION OF EXPERIMENTAL COLITIS
    Prescott, D. C.
    Atkinson, B.
    McKay, D. M.
    Waterhouse, C.
    INFLAMMATION RESEARCH, 2011, 60 : 34 - 34
  • [38] Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110δ mutations
    Cornillet-Lefebvre, P
    Cuccuini, W
    Bardet, V
    Tamburini, J
    Gillot, L
    Ifrah, N
    Nguyen, P
    Dreyfus, F
    Mayeux, P
    Lacombe, C
    Bouscary, D
    LEUKEMIA, 2006, 20 (02) : 374 - 376
  • [39] P110δ Phosphoinositide 3-Kinase Uncouples Colitis from Colitis-Associated Cancer
    Kok, Klaartje
    ten Kate, Fiebo J.
    Offerhaus, Johan
    Peppelenbosch, Maikel P.
    Hommes, Daniel
    GASTROENTEROLOGY, 2009, 136 (05) : A246 - A246
  • [40] Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110α inhibitors
    Yiping Li
    Yawen Wang
    Fuqiang Zhang
    Journal of Molecular Modeling, 2010, 16 : 1449 - 1460